Colorectal cancer (CRC) is a predominant malignancy worldwide, being the fourth most
common cause of mortality and morbidity. The CRC incidence in adolescents, young adults …

Proton pump inhibitors (PPIs) are common medications within the practice of
gastroenterology. These drugs, which act through the irreversible inhibition of the …

Objectives Bacteriome and virome alterations are associated with colorectal cancer (CRC).
Nevertheless, the gut fungal microbiota in CRC remains largely unexplored. We aimed to …

Over the past few years, microbiome research has dramatically reshaped our understanding
of human biology. New insights range from an enhanced understanding of how microbes …

Simple Summary Colorectal cancer (CRC) is the second-leading cause of cancer-related
deaths worldwide. In this review article, we examine the role of gut microbiota in the …

Gut microbiota dysbiosis has been considered to be an important risk factor that contributes
to coronary artery disease (CAD), but limited evidence exists about the involvement of gut …

Dysbiosis of the gut microbiome has been associated with the development of colorectal
cancer (CRC). Gut microbiota is involved in the metabolic transformations of dietary …

The link between gut microbiota and the development of colorectal cancer has been
investigated. An imbalance in the gut microbiota promotes the progress of colorectal …

Accumulating evidence indicates that breakdown of the+ protective mucosal barrier of the
gut plays a role in colorectal cancer (CRC) development. Inflammation and oxidative stress …

Colorectal cancer (CRC) is the second most common cause of cancer death in the world.
Both modifiable and nonmodifiable risk factors play a significant role in the pathogenesis of …